Clinical Trial Update: Antiandrogen Therapy and Radiation Therapy With or Without Docetaxel in Treating Patients With Prostate Cancer That Has Been Removed by Surgery [Phase 2, Phase 3]

View source ↗

Summary

Clinical trial update describing Phase 2/3 evaluation of antiandrogen therapy with radiation, with or without the chemotherapy drug docetaxel, in patients with …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Adenocarcinoma
• Prostate Cancer

Drugs mentioned

• Antiandrogen therapy
• DOCETAXEL (DOCETAXEL)

Snippet

Sponsor: NRG Oncology | Conditions: Stage I Prostate Adenocarcinoma AJCC v7, Stage II Prostate Adenocarcinoma AJCC v7 | Phase 2, Phase 3 | Status: COMPLETED